DK1761478T3 - En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder - Google Patents
En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarderInfo
- Publication number
- DK1761478T3 DK1761478T3 DK05771573T DK05771573T DK1761478T3 DK 1761478 T3 DK1761478 T3 DK 1761478T3 DK 05771573 T DK05771573 T DK 05771573T DK 05771573 T DK05771573 T DK 05771573T DK 1761478 T3 DK1761478 T3 DK 1761478T3
- Authority
- DK
- Denmark
- Prior art keywords
- atomoxetine
- impurity
- impurities
- isolated
- producing
- Prior art date
Links
- 229960002430 atomoxetine Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 title 2
- 239000012535 impurity Substances 0.000 title 2
- LUCXVPAZUDVVBT-UNTBIKODSA-N atomoxetine hydrochloride Chemical compound Cl.O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C LUCXVPAZUDVVBT-UNTBIKODSA-N 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 abstract 1
- 229960002828 atomoxetine hydrochloride Drugs 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000010959 commercial synthesis reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58364104P | 2004-06-28 | 2004-06-28 | |
| US58364404P | 2004-06-28 | 2004-06-28 | |
| US58364304P | 2004-06-28 | 2004-06-28 | |
| US60971604P | 2004-09-14 | 2004-09-14 | |
| US62206504P | 2004-10-25 | 2004-10-25 | |
| US65233205P | 2005-02-11 | 2005-02-11 | |
| US65233005P | 2005-02-11 | 2005-02-11 | |
| US65233105P | 2005-02-11 | 2005-02-11 | |
| US66666605P | 2005-03-30 | 2005-03-30 | |
| US67536905P | 2005-04-26 | 2005-04-26 | |
| US68977805P | 2005-06-09 | 2005-06-09 | |
| US69073805P | 2005-06-14 | 2005-06-14 | |
| PCT/US2005/023423 WO2006004979A2 (en) | 2004-06-28 | 2005-06-28 | An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1761478T3 true DK1761478T3 (da) | 2008-12-15 |
Family
ID=35783354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05771573T DK1761478T3 (da) | 2004-06-28 | 2005-06-28 | En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US7439398B2 (da) |
| EP (4) | EP1761478B1 (da) |
| JP (1) | JP2008504302A (da) |
| KR (2) | KR20070001250A (da) |
| AT (1) | ATE407111T1 (da) |
| CA (5) | CA2561387A1 (da) |
| DK (1) | DK1761478T3 (da) |
| ES (1) | ES2313387T3 (da) |
| IL (5) | IL180354A0 (da) |
| PL (1) | PL1761478T3 (da) |
| WO (5) | WO2006004976A2 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7439399B2 (en) * | 2004-06-28 | 2008-10-21 | Teva Pharmaceutical Fine Chemicals | Processes for the preparation of atomoxetine hydrochloride |
| ATE407111T1 (de) | 2004-06-28 | 2008-09-15 | Teva Pharm Fine Chemicals Srl | Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards |
| CA2568629A1 (en) | 2004-07-22 | 2006-02-23 | Teva Pharmaceutical Fine Chemicals S.R.L. | Polymorphs of atomoxetine hydrochloride |
| EP1794112A4 (en) * | 2004-09-27 | 2009-11-04 | Reddys Lab Ltd Dr | SYNTHESIS OF ATOMEXETINE HYDROCHLORIDE |
| JP2008501721A (ja) * | 2005-04-05 | 2008-01-24 | テバ ファーマシューティカル ファイン ケミカルズ ソチエタ レスポンサビリタ リミテ | 安定性アトモキセチン塩酸塩、その調製方法及びその安定性の分析的調節 |
| US8515185B2 (en) * | 2009-11-25 | 2013-08-20 | Google Inc. | On-screen guideline-based selective text recognition |
| WO2011161690A1 (en) * | 2010-06-23 | 2011-12-29 | Symed Labs Limited | Processes for the preparation of (+)-n,n-dimethyl-2-[1-(naphthalenyloxy) ethyl] benzene methanamine and intermediates thereof |
| US9604906B2 (en) * | 2013-07-02 | 2017-03-28 | Zcl Chemicals Limited | Process for the preparation of 3-aryloxy-3-phenylpropylamine and salt thereof |
| CN104628768A (zh) * | 2015-03-06 | 2015-05-20 | 江苏正大清江制药有限公司 | 一种伊班膦酸钠的制备方法 |
| CN108929236A (zh) * | 2017-05-26 | 2018-12-04 | 万特制药(海南)有限公司 | 盐酸托莫西汀的制备 |
| CN110194719B (zh) * | 2019-06-12 | 2020-05-15 | 山东大学 | 一种r-(-)-盐酸阿托莫西汀的制备方法 |
| CN113336654B (zh) * | 2020-02-18 | 2022-12-09 | 上海医药工业研究院 | 一种n-甲基-3-(2-甲基苯氧基)苯丙胺的制备方法 |
| CN113358773B (zh) * | 2021-05-21 | 2022-09-13 | 健民药业集团股份有限公司 | 一种检测盐酸托莫西汀对映异构体的反相液相色谱方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018895A (en) * | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
| US4194009A (en) * | 1974-01-10 | 1980-03-18 | Eli Lilly And Company | Aryloxyphenylpropylamines for obtaining a psychotropic effect |
| GR75395B (da) * | 1980-11-14 | 1984-07-13 | Lilly Co Eli | |
| US4777291A (en) | 1985-02-27 | 1988-10-11 | Eli Lilly And Company | Racemization process |
| DK630987D0 (da) * | 1987-12-01 | 1987-12-01 | Ferrosan As | Aryloxyphenylpropylaminer, deres fremstilling og anvendelse |
| US4868344A (en) * | 1988-03-30 | 1989-09-19 | Aldrich-Boranes, Inc. | Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein |
| DE4123253A1 (de) | 1991-07-15 | 1993-01-21 | Schneider Manfred Prof Dr | Verfahren zur enzymatischen racematspaltung halogenierter arylalkanole |
| HU9202128D0 (en) | 1992-06-26 | 1992-10-28 | Richter Gedeon Vegyeszet | Method for producing n-methyl-(3-phenyl-3-(4-[trifluoro-methyl])-phenooxi-)-amine |
| US5658590A (en) | 1995-01-11 | 1997-08-19 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
| GB9812413D0 (en) | 1998-06-10 | 1998-08-05 | Glaxo Group Ltd | Compound and its use |
| AU3219800A (en) | 1999-03-29 | 2000-10-16 | Eli Lilly And Company | Stereospecific method for preparing tomoxetine and intermediates thereof |
| CA2362185C (en) * | 1999-04-09 | 2009-06-02 | Eli Lilly And Company | Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof |
| WO2000064855A1 (en) | 1999-04-26 | 2000-11-02 | Eli Lilly And Company | Epimerization reaction for the production of r-fluoxetine |
| ATE407111T1 (de) | 2004-06-28 | 2008-09-15 | Teva Pharm Fine Chemicals Srl | Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards |
| CA2568629A1 (en) | 2004-07-22 | 2006-02-23 | Teva Pharmaceutical Fine Chemicals S.R.L. | Polymorphs of atomoxetine hydrochloride |
-
2005
- 2005-06-28 AT AT05771573T patent/ATE407111T1/de not_active IP Right Cessation
- 2005-06-28 CA CA002561387A patent/CA2561387A1/en not_active Abandoned
- 2005-06-28 WO PCT/US2005/023419 patent/WO2006004976A2/en not_active Ceased
- 2005-06-28 ES ES05771573T patent/ES2313387T3/es not_active Expired - Lifetime
- 2005-06-28 EP EP05771573A patent/EP1761478B1/en not_active Expired - Lifetime
- 2005-06-28 WO PCT/US2005/023273 patent/WO2006004923A2/en not_active Ceased
- 2005-06-28 CA CA002561386A patent/CA2561386A1/en not_active Abandoned
- 2005-06-28 WO PCT/US2005/023421 patent/WO2006004977A2/en not_active Ceased
- 2005-06-28 KR KR1020067022415A patent/KR20070001250A/ko not_active Ceased
- 2005-06-28 US US11/170,378 patent/US7439398B2/en not_active Expired - Fee Related
- 2005-06-28 US US11/170,429 patent/US7355078B2/en not_active Expired - Fee Related
- 2005-06-28 US US11/170,379 patent/US7317127B2/en not_active Expired - Fee Related
- 2005-06-28 WO PCT/US2005/023412 patent/WO2006068662A1/en not_active Ceased
- 2005-06-28 DK DK05771573T patent/DK1761478T3/da active
- 2005-06-28 EP EP05771266A patent/EP1687254A2/en not_active Withdrawn
- 2005-06-28 CA CA002561866A patent/CA2561866A1/en not_active Abandoned
- 2005-06-28 CA CA002560899A patent/CA2560899A1/en not_active Abandoned
- 2005-06-28 CA CA002561015A patent/CA2561015A1/en not_active Abandoned
- 2005-06-28 US US11/170,430 patent/US7378553B2/en not_active Expired - Fee Related
- 2005-06-28 EP EP05856869A patent/EP1704138A1/en not_active Withdrawn
- 2005-06-28 US US11/169,995 patent/US7507861B2/en not_active Expired - Fee Related
- 2005-06-28 WO PCT/US2005/023423 patent/WO2006004979A2/en not_active Ceased
- 2005-06-28 PL PL05771573T patent/PL1761478T3/pl unknown
- 2005-06-28 EP EP05769184A patent/EP1682485A2/en active Pending
- 2005-06-28 JP JP2007518380A patent/JP2008504302A/ja active Pending
- 2005-06-28 KR KR1020067022414A patent/KR20070057703A/ko not_active Ceased
-
2006
- 2006-12-26 IL IL180354A patent/IL180354A0/en unknown
- 2006-12-26 IL IL180357A patent/IL180357A0/en unknown
- 2006-12-26 IL IL180356A patent/IL180356A0/en unknown
- 2006-12-26 IL IL180355A patent/IL180355A0/en unknown
- 2006-12-26 IL IL180353A patent/IL180353A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1761478T3 (da) | En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder | |
| WO2006027705A3 (en) | Synthesis of triethylenetetramines | |
| UA93861C2 (uk) | Спосіб одержання n-фенілпіразол-1-карбоксамідів та сполука аніліну | |
| UA95600C2 (en) | Synthesis scheme for lacosamide | |
| UA100367C2 (uk) | Спосіб одержання мемантину і його гідрохлориду | |
| NO20072494L (no) | Fast farmasoytisk forbindelse som omfatter donepezil-hydroklorid | |
| CY1108804T1 (el) | Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης. | |
| TW200740769A (en) | Novel process | |
| MX2007010141A (es) | Procesos para la preparacion de intermedios de linezolid. | |
| TW200612959A (en) | Method for preparing hydroxamic acids | |
| NO20064884L (no) | Kjemisk fremgangsmate og ny krystallinsk form | |
| TW200740729A (en) | Methods for preparing glutamic acid derivatives | |
| UA85701C2 (ru) | Способ получения ингибиторов триптазы | |
| NO20076307L (no) | Fremgangsmater for a fremstille biarylurinstoffer og analoger derav | |
| TW200738650A (en) | Process for synthesis of aryloxy diaminopyrimidines | |
| EA200600977A1 (ru) | Способы получения венлафаксина и формы i венлафаксина гидрохлорида | |
| BRPI0519785A2 (pt) | processo para a preparação de isocianatos de tiofenossulfonila | |
| EA200701163A1 (ru) | Способ получения анилинов | |
| TW200621734A (en) | Process for preparing diarylcycloalkyl derivatives | |
| EA200601563A1 (ru) | Водно-изопропанольный сольват оланзапина | |
| ATE417055T1 (de) | Steroid modifizierte solatriosen | |
| BRPI0516009A (pt) | processo para a produção da 2-cloro-4-nitroimidazol | |
| MX2007008125A (es) | Procedimiento para preparar aminas benciladas. | |
| CY1106649T1 (el) | Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων | |
| WO2009037230A3 (en) | Improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters |